Stage II Breast Cancer Active Not Recruiting Phase 2 Trials for Filgrastim (DB00099)

IndicationStatusPhase
DBCOND0029484 (Stage II Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00513695Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast CancerTreatment